The Discounted Cash Flow (DCF) valuation of Evoke Pharma Inc (EVOK) is (1,312.95) USD. With the latest stock price at 2.63 USD, the upside of Evoke Pharma Inc based on DCF is -50075.1%.
Based on the latest price of 2.63 USD and our DCF valuation, Evoke Pharma Inc (EVOK) is a sell. selling EVOK stocks now will result in a potential gain of 50075.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.6% - 5.4% | 5.0% |
| Long-term Growth Rate | 3.0% - 4.4% | 3.7% |
| Fair Price | (6,862.95) - (733.33) | (1,312.95) |
| Upside | -261326.6% - -28012.9% | -50075.1% |